Key statistics
On Friday, 4D Molecular Therapeutics Inc (FDMT:NSQ) closed at 9.35, -24.23% below its 52-week high of 12.34, set on Oct 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.39 |
|---|---|
| High | 9.78 |
| Low | 9.28 |
| Bid | 9.27 |
| Offer | 9.50 |
| Previous close | 9.36 |
| Average volume | 752.03k |
|---|---|
| Shares outstanding | 51.01m |
| Free float | 49.16m |
| P/E (TTM) | -- |
| Market cap | 476.92m USD |
| EPS (TTM) | -3.74 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- 4DMT Announces New Employment Inducement Grants
- 4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
- 4DMT Announces New Employment Inducement Grants
- 4DMT Provides Company Update and Anticipated Development Milestones for 2026
- 4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
- 4DMT Announces New Employment Inducement Grants
- 4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
- 4DMT to Participate in 8th Annual Evercore Healthcare Conference
- 4DMT Appoints Kristian Humer as Chief Financial Officer
- 4DMT Announces New Employment Inducement Grants
More ▼
